Ogkologos

4396 ΔΗΜΟΣΙΕΥΣΕΙΣ 0 ΣΧΟΛΙΑ

ViPOR Regimen Associated with Durable Remissions in Patients with Specific Molecular...

Ogkologos - 7 Αυγούστου, 2024

More Immunotherapy Options Approved for Treating Endometrial Cancer

Ogkologos - 6 Αυγούστου, 2024

FDA Approves Blinatumomab as Consolidation for CD19-positive Philadelphia Chromosome-negative B-Cell Precursor...

Ogkologos - 6 Αυγούστου, 2024

Telisotuzumab Vedotin Associated with Durable Responses in c-Met Protein–Overexpressing Non-Squamous EGFR-wild-type...

Ogkologos - 5 Αυγούστου, 2024

Screening People at High Risk for Pancreatic Cancer May Help Them...

Ogkologos - 2 Αυγούστου, 2024

EMA Recommends Extension of Therapeutic Indications for Durvalumab to Patients with...

Ogkologos - 2 Αυγούστου, 2024

FDA Grants Accelerated Approval to Epcoritamab-bysp for Relapsed or Refractory Follicular...

Ogkologos - 31 Ιουλίου, 2024

Sacituzumab Govitecan Does Not Demonstrate a Statistically Significant OS Improvement in...

Ogkologos - 30 Ιουλίου, 2024

AI-Based Score as a Selection Tool for Supplemental MRI After Negative...

Ogkologos - 29 Ιουλίου, 2024

Neoadjuvant Camrelizumab Plus Chemotherapy Demonstrate Superior pCR Compared to Chemotherapy Alone...

Ogkologos - 29 Ιουλίου, 2024

1...747576...440 Σελίδα 75 από 440

MOST POPULAR

Themes in Improving Supportive Care for People With Cancer: 2022 MASCC...

1 Σεπτεμβρίου, 2022

ESMO Launches First Congress on Artificial Intelligence and Digital Oncology: A...

12 Νοεμβρίου, 2025

2020 round-up: Our biggest cancer stories of the year

20 Δεκεμβρίου, 2020

Surveillance and Early Cancer Detection are Associated with Improved Survival in...

1 Σεπτεμβρίου, 2021

Φόρτωση περισσοτέρων

ViPOR Regimen Associated with Durable Remissions in Patients with Specific Molecular...

More Immunotherapy Options Approved for Treating Endometrial Cancer

FDA Approves Blinatumomab as Consolidation for CD19-positive Philadelphia Chromosome-negative B-Cell Precursor...

Telisotuzumab Vedotin Associated with Durable Responses in c-Met Protein–Overexpressing Non-Squamous EGFR-wild-type...

Screening People at High Risk for Pancreatic Cancer May Help Them...

EMA Recommends Extension of Therapeutic Indications for Durvalumab to Patients with...

FDA Grants Accelerated Approval to Epcoritamab-bysp for Relapsed or Refractory Follicular...

Sacituzumab Govitecan Does Not Demonstrate a Statistically Significant OS Improvement in...

AI-Based Score as a Selection Tool for Supplemental MRI After Negative...

Neoadjuvant Camrelizumab Plus Chemotherapy Demonstrate Superior pCR Compared to Chemotherapy Alone...

MOST POPULAR

Themes in Improving Supportive Care for People With Cancer: 2022 MASCC...

ESMO Launches First Congress on Artificial Intelligence and Digital Oncology: A...

2020 round-up: Our biggest cancer stories of the year

Surveillance and Early Cancer Detection are Associated with Improved Survival in...

HOT NEWS

England slips further off-track for smokefree 2030 target

Nous-209 Efficiently Stimulates Immunity Against Neoantigens in Lynch Syndrome Carriers

Increased Efficacy of Pembrolizumab or Pembrolizumab-Chemotherapy with Increasing PD-L1 Expression in...

Mom Fighting Breast Cancer Says Her Haunted House Is Something To...

ΔΗΜΟΦΙΛΕΊΣ ΘΈΣΕΙΣ

ΚΑΡΚΙΝΟΣ ΘΥΜΟΥ ΑΔΕΝΑ (ΘΥΜΩΜΑ)

ΣΤΑΤΙΣΤΙΚΑ

ΚΕΝΤΡΙΚΟΥ ΝΕΥΡΙΚΟΥ ΣΥΣΤΗΜΑΤΟΣ

ΔΗΜΟΦΙΛΗ ΚΑΤΗΓΟΡΙΑ